Literature DB >> 23078908

Bronchoalveolar lavage lateral-flow device test for invasive pulmonary aspergillosis diagnosis in haematological malignancy and solid organ transplant patients.

Martin Hoenigl, Christoph Koidl, Wiebke Duettmann, Katharina Seeber, Jasmin Wagner, Walter Buzina, Albert Wölfler, Reinhard B Raggam, Christopher R Thornton, Robert Krause.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2012        PMID： 23078908     DOI： 10.1016/j.jinf.2012.10.003

Source DB:  PubMed          Journal:  J Infect        ISSN： 0163-4453            Impact factor:   6.072


× No keyword cloud information.
  19 in total

1.  Evaluation of real-time PCR, galactomannan enzyme-linked immunosorbent assay (ELISA), and a novel lateral-flow device for diagnosis of invasive aspergillosis.

Authors:  P Lewis White; Christian Parr; Christopher Thornton; Rosemary A Barnes
Journal:  J Clin Microbiol       Date:  2013-03-13       Impact factor: 5.948

2.  Aspergillus-Specific Lateral-Flow Device and Real-Time PCR Testing of Bronchoalveolar Lavage Fluid: a Combination Biomarker Approach for Clinical Diagnosis of Invasive Pulmonary Aspergillosis.

Authors:  Gemma L Johnson; Shah-Jalal Sarker; Francesco Nannini; Arianna Ferrini; Emma Taylor; Cornelia Lass-Flörl; Wolfgang Mutschlechner; Stephen A Bustin; Samir G Agrawal
Journal:  J Clin Microbiol       Date:  2015-04-22       Impact factor: 5.948

3.  Performance of galactomannan, beta-d-glucan, Aspergillus lateral-flow device, conventional culture, and PCR tests with bronchoalveolar lavage fluid for diagnosis of invasive pulmonary aspergillosis.

Authors:  M Hoenigl; J Prattes; B Spiess; J Wagner; F Prueller; R B Raggam; V Posch; W Duettmann; K Hoenigl; A Wölfler; C Koidl; W Buzina; M Reinwald; C R Thornton; R Krause; D Buchheidt
Journal:  J Clin Microbiol       Date:  2014-03-26       Impact factor: 5.948

4.  Potential factors for inadequate voriconazole plasma concentrations in intensive care unit patients and patients with hematological malignancies.

Authors:  Martin Hoenigl; Wiebke Duettmann; Reinhard B Raggam; Katharina Seeber; Katharina Troppan; Sonja Fruhwald; Florian Prueller; Jasmin Wagner; Thomas Valentin; Ines Zollner-Schwetz; Albert Wölfler; Robert Krause
Journal:  Antimicrob Agents Chemother       Date:  2013-04-29       Impact factor: 5.191

5.  Long-term stability at -20 °C of Aspergillus galactomannan in serum and bronchoalveolar lavage specimens.

Authors:  L Joseph Wheat; M Hong Nguyen; Barbara D Alexander; David Denning; Angela M Caliendo; G Marshall Lyon; Lindsey R Baden; Francisco M Marty; Cornelius Clancy; Emily Kirsch; Pamela Noth; John Witt; Michele Sugrue; John R Wingard
Journal:  J Clin Microbiol       Date:  2014-04-09       Impact factor: 5.948

Review 6.  Invasive pulmonary aspergillosis: current diagnostic methodologies and a new molecular approach.

Authors:  S Moura; L Cerqueira; A Almeida
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2018-05-13       Impact factor: 3.267

Review 7.  Current challenges in the microbiological diagnosis of invasive aspergillosis.

Authors:  Jesús Guinea; Emilio Bouza
Journal:  Mycopathologia       Date:  2014-06-20       Impact factor: 2.574

8.  Comparison of a novel Aspergillus lateral-flow device and the Platelia® galactomannan assay for the diagnosis of invasive aspergillosis following haematopoietic stem cell transplantation.

Authors:  J Held; T Schmidt; C R Thornton; E Kotter; H Bertz
Journal:  Infection       Date:  2013-05-10       Impact factor: 3.553

9.  Interlaboratory and interstudy reproducibility of a novel lateral-flow device and influence of antifungal therapy on detection of invasive pulmonary aspergillosis.

Authors:  Nathan P Wiederhold; Laura K Najvar; Rosie Bocanegra; William R Kirkpatrick; Thomas F Patterson; Christopher R Thornton
Journal:  J Clin Microbiol       Date:  2012-11-21       Impact factor: 5.948

Review 10.  [Aspergillus in airway material : Ignore or treat?]

Authors:  H J F Salzer; C Lange; M Hönigl
Journal:  Internist (Berl)       Date:  2017-11       Impact factor: 0.743
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.